Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

被引:366
作者
Perros, Frederic [1 ,2 ,3 ]
Montani, David [1 ,2 ]
Dorfmueller, Peter [1 ,2 ]
Durand-Gasselin, Ingrid [2 ]
Tcherakian, Colas [1 ,2 ]
Le Pavec, Jerome [1 ]
Mazmanian, Michel [3 ]
Fadel, Elie [3 ]
Mussot, Sacha [3 ]
Mercier, Olaf [3 ]
Herve, Philippe [3 ]
Emilie, Dominique [2 ]
Eddahibi, Saadia [4 ]
Simonneau, Gerald [1 ]
Souza, Rogerio [1 ,2 ]
Humbert, Marc [1 ,2 ]
机构
[1] Univ Paris 11, Serv Pneumol & Reanimat Resp,Hop Antoine Beclere, UPRES EA 2705,Inst Paris Sud Cytokines,Assistance, Ctr Natl Reference Hypertens Arterielle Pulm, F-92140 Clamart, France
[2] INSERM U764, Clamart, France
[3] Univ Paris 11, UPRES EA 2705, Chirurg Expt Lab, Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France
[4] Hop Henri Mondor, Assistance Publ Hop Paris, Dept Physiol Explorat Fonct, F-94010 Creteil, France
关键词
imatinib; pulmonary arterial hypertension; platelet-derived growth factor; remodeling; smooth muscle cells;
D O I
10.1164/rccm.200707-1037OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale; Platelet-derived growth factor (PDGF) promotes the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs), and may play a role in the progression of pulmonary arterial hypertension (PAH), a condition characterized by proliferation of PASMCs resulting in the obstruction of small pulmonary arteries. Objectives: To analyze the expression and pathogenic role of PDGF in idiopathic PAH. Methods: PDGF and PDGF receptor mRNA expression was studied by real-time reverse tran scription-polymerase chain reaction performed on laser capture microdissected pulmonary arteries from patients undergoing lung transplantation for idiopathic PAH. Immunohistochemistry was used to localize PDGF, PDGF receptors, and phosphorylated PDGFR-beta. The effects of imatinib on PDGF-B-induced proliferation and chemotaxis were tested on human PA5MCs. Measurements and Main Results: PDGF-A, PDGF-B, PDGFR-alpha, and PDGFR-beta mRNA expression was increased in small pulmonary arteries from patients displaying idiopathic PAH, as compared with control subjects. Western blotanalysis revealed a significant increase in protein expression of PDGFR-beta in PAH lungs, as compared with control lungs. In small remodeled pulmonary arteries, PDGF-A and PDCF-B mainly localized to PASMCs and endothelial cells (perivascular inflammatory infiltrates, when present, showed intensive staining), PDGFR-alpha and PDGFR-beta mainly stained PASMCs and to a lesser extent endothelial cells. Proliferating pulmonary vascular lesions stained phosphorylated PDGFR-beta. PDGF-BB-induced proliferation and migration of PASMCs were inhibited by imatinib. This effect was not due to PASMC apoptosis. Conclusions: PDGF may play an important role in human PAH. Novel therapeutic strategies targeting the PDGF pathway should be tested in clinical trials.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 26 条
[1]   Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus [J].
Balasubramaniam, V ;
Le Cras, TD ;
Ivy, DD ;
Grover, TR ;
Kinsella, JP ;
Abman, SH .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 284 (05) :L826-L833
[2]   VASOCONSTRICTION - A NEW ACTIVITY FOR PLATELET-DERIVED GROWTH-FACTOR [J].
BERK, BC ;
ALEXANDER, RW ;
BROCK, TA ;
GIMBRONE, MA ;
WEBB, RC .
SCIENCE, 1986, 232 (4746) :87-90
[3]   Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes - Distinct responses to stimuli [J].
Deng, DXF ;
Spin, JM ;
Tsalenko, A ;
Vailaya, A ;
Ben-Dor, A ;
Yakhini, Z ;
Tsao, P ;
Bruhn, L ;
Quertermous, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) :1058-1065
[4]   Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle [J].
Deshpande, NN ;
Sorescu, D ;
Seshiah, P ;
Ushio-Fukai, M ;
Akers, M ;
Yin, QQ ;
Griendling, KK .
ANTIOXIDANTS & REDOX SIGNALING, 2002, 4 (05) :845-854
[5]   Chemokine RANTES in severe pulmonary arterial hypertension [J].
Dorfmüller, P ;
Zarka, V ;
Durand-Gasselin, I ;
Monti, G ;
Balabanian, K ;
Garcia, G ;
Capron, F ;
Coulomb-Lherminé, A ;
Marfaing-Koka, A ;
Simonneau, G ;
Emilie, D ;
Humbert, M .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (04) :534-539
[6]   Imatinib as a paradigm of targeted therapies [J].
Druker, BJ .
ADVANCES IN CANCER RESEARCH, VOL 91, 2004, 91 :1-+
[7]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[8]  
Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI200112805
[9]   Imatinib for the treatment of pulmonary arterial hypertension [J].
Ghofrani, HA ;
Seeger, W ;
Grimminger, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1412-1413
[10]   Mechanism of action and in vivo role of platelet-derived growth factor [J].
Heldin, CH ;
Westermark, B .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1283-1316